NOVAGAMD

Novel antigens for human gamma delta T cells

Coordinatore	KING'S COLLEGE LONDON    more  Organization address address: Strand city: LONDON postcode: WC2R 2LS contact info Titolo: Mr. Nome: Paul Cognome: Labbett Email: send email Telefono: + 44 0)207 848 8184 Fax: +44 (0)207 848 8187
Nazionalità Coordinatore	United Kingdom [UK]
Totale costo	171˙740 €
EC contributo	171˙740 €
Programma	FP7-PEOPLE Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
Code Call	FP7-PEOPLE-2009-IEF
Funding Scheme	MC-IEF
Anno di inizio	2010
Periodo (anno-mese-giorno)	2010-08-01   -   2012-07-31

 Partecipanti

#	participant	country	role	EC contrib. [€]
1	KING'S COLLEGE LONDON  Organization address address: Strand city: LONDON postcode: WC2R 2LS contact info Titolo: Mr. Nome: Paul Cognome: Labbett Email: send email Telefono: + 44 0)207 848 8184 Fax: +44 (0)207 848 8187	UK (LONDON)	coordinator	171˙740.80

Mappa

 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

 Obiettivo del progetto (Objective)

'T lymphocytes bearing gamma delta T cell receptors (TCR) make crucial contributions to tissue-surveillance of infection and non-microbial stress. Although these cells may recognise dysregulated tissues via their activating NKG2D receptor, we remain very ignorant of stress-related molecules that may bind the gamma/delta TCR directly. Much work has focussed on peripheral blood gamma delta T cells expressing Vgamma9-Vdelta2 TCRs. Recently however, several Vgamma9-Vdelta2-negative clones were isolated which react both to cytomegalovirus-infected cells and to colonic tumours. This has led to the identification of Endothelial cell Protein C Receptor (EPCR) as a TCR target of one such clone. This is only the third gamma delta TCR ligand validated biochemically. I shall now assess the generality of EPCR reactivity among human gamma delta T cells. Using ELISpot technology, I can apply a very sensitive means to investigate cytokine production by gamma delta T cells from cells of donors of various ages and health status. Moreover, since EPCR is strongly conserved, I shall extend the project to mouse. The identification of EPCR activity in mice would substantially enhance the capacity to dissect the biology of this novel response. Finally, I shall also investigate candidate ligands for aVgamma9-Vdelta2-negative clone that does not bind EPCR.'